Pub Date : 2025-12-11eCollection Date: 2025-01-01DOI: 10.12688/wellcomeopenres.24070.2
Oluchi C Maduka, Simisola O Akintola
Introduction: Data science health research (DSHR) presents new ethical challenges to the traditional model of human subject research, particularly by enabling data processing without the consent of data subjects. Although the current research governance framework makes informed consent a cornerstone of ethical research practices, obtaining individual consent can often be impractical in DSHR. This paper explores the alignment of DSHR with African customary governance and communal lifestyles as a framework for ethical research oversight.
Methodology: This paper adopts a case study methodology, using a comparative analysis of decolonisation and self-regulation in health research across five African countries-Nigeria, Kenya, Ghana, Uganda, and South Africa. The study combines doctrinal analysis of legal and policy frameworks with reviews of peer-reviewed literature, case law, and diverse online resources such as PubMed, Google Scholar, HeinOnline, and government websites.
Results: Data science health research challenges traditional biomedical ethics by enabling data processing without consent, thereby questioning the longstanding principle that informed consent is a prerequisite for ethical research. However, this principle has been widely contested as a universal standard, particularly in African contexts where decision-making is often communal rather than individualistic. The case studies illustrate that while informed consent remains a normative requirement, largely to satisfy the expectations of funding bodies, communal approval is paramount. Furthermore, religious and cultural traditions often accommodate forms of paternalistic consent, reinforcing collective decision-making structures.
Conclusion: Given that African societies emphasise communal governance, the ethical challenges posed by DSHR, particularly regarding consent, may be less pronounced in Africa. However, decolonisation and self-regulation are not merely theoretical constructs, but a practical and necessary process that requires deliberate action. Unless African leaders take decisive steps to restructure governance, prioritise self-reliance, and invest in homegrown research and development, the discourse on decolonising DSHR in Africa will remain purely theoretical, lacking the practical implementation needed for real change.
{"title":"Decolonisation and Self-Regulation as Alternative Paths to Data Science Health Research Governance in Africa.","authors":"Oluchi C Maduka, Simisola O Akintola","doi":"10.12688/wellcomeopenres.24070.2","DOIUrl":"10.12688/wellcomeopenres.24070.2","url":null,"abstract":"<p><strong>Introduction: </strong>Data science health research (DSHR) presents new ethical challenges to the traditional model of human subject research, particularly by enabling data processing without the consent of data subjects. Although the current research governance framework makes informed consent a cornerstone of ethical research practices, obtaining individual consent can often be impractical in DSHR. This paper explores the alignment of DSHR with African customary governance and communal lifestyles as a framework for ethical research oversight.</p><p><strong>Methodology: </strong>This paper adopts a case study methodology, using a comparative analysis of decolonisation and self-regulation in health research across five African countries-Nigeria, Kenya, Ghana, Uganda, and South Africa. The study combines doctrinal analysis of legal and policy frameworks with reviews of peer-reviewed literature, case law, and diverse online resources such as PubMed, Google Scholar, HeinOnline, and government websites.</p><p><strong>Results: </strong>Data science health research challenges traditional biomedical ethics by enabling data processing without consent, thereby questioning the longstanding principle that informed consent is a prerequisite for ethical research. However, this principle has been widely contested as a universal standard, particularly in African contexts where decision-making is often communal rather than individualistic. The case studies illustrate that while informed consent remains a normative requirement, largely to satisfy the expectations of funding bodies, communal approval is paramount. Furthermore, religious and cultural traditions often accommodate forms of paternalistic consent, reinforcing collective decision-making structures.</p><p><strong>Conclusion: </strong>Given that African societies emphasise communal governance, the ethical challenges posed by DSHR, particularly regarding consent, may be less pronounced in Africa. However, decolonisation and self-regulation are not merely theoretical constructs, but a practical and necessary process that requires deliberate action. Unless African leaders take decisive steps to restructure governance, prioritise self-reliance, and invest in homegrown research and development, the discourse on decolonising DSHR in Africa will remain purely theoretical, lacking the practical implementation needed for real change.</p>","PeriodicalId":23677,"journal":{"name":"Wellcome Open Research","volume":"10 ","pages":"380"},"PeriodicalIF":0.0,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12853021/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146107425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-11eCollection Date: 2022-01-01DOI: 10.12688/wellcomeopenres.17908.4
Nickson Murunga, Bryan Nyawanda, Joyce U Nyiro, Grieven P Otieno, Everlyn Kamau, Charles N Agoti, Clement Lewa, Alex Gichuki, Martin Mutunga, Nancy Otieno, Lilian Mayieka, Melvin Ochieng, Gilbert Kikwai, Elizabeth Hunsperger, Clayton Onyango, Gideon Emukule, Godfrey Bigogo, Jennifer R Verani, Sandra S Chaves, D James Nokes, Patrick K Munywoki
Background: Acute respiratory illnesses (ARI) are a major cause of morbidity and mortality globally. With (re)emergence of novel viruses and increased access to childhood bacterial vaccines, viruses have assumed greater importance in the aetiology of ARI. There are now promising candidate vaccines against some of the most common endemic respiratory viruses. Optimal delivery strategies for these vaccines, and the need for interventions against other respiratory viruses, requires geographically diverse data capturing temporal variations in virus circulation.
Methods: We leveraged three health facility-based respiratory illness surveillance platforms operating in 11 sites across Kenya. Nasopharyngeal (NP) and/or oropharyngeal (OP) specimens, patient demographic, and clinical characteristics were collected in 2014 from individuals of various ages presenting with respiratory symptoms at the surveillance facilities. Real time multiplex polymerase chain reaction was used to detect rhinoviruses, respiratory syncytial virus (RSV), influenza virus, human coronaviruses (hCoV), and adenoviruses.
Results: From 11 sites, 5451 NP/OP specimens were collected and tested from patients. Of these, 40.2% were positive for at least one of the targeted respiratory viruses. The most frequently detected were rhinoviruses (17.0%) and RSV A/B (10.5%), followed by influenza A (6.2%), adenovirus (6.0%) and hCoV (4.2%). RSV was most prevalent among infants aged <12 months old (18.9%), adenovirus among children aged 12-23 months old (11.0%), influenza A among children aged 24-59 months (9.3%), and rhinovirus across all age groups (range, 12.7-19.0%). RSV had a higher virus positivity in the inpatient setting (12.5%) compared to outpatient setting (4.8%). The overall percent virus positivity varied by surveillance site, health facility type and case definition used in surveillance.
Conclusions: We identify rhinoviruses, RSV, and influenza A as the most prevalent respiratory viruses. Higher RSV positivity in inpatients, and in infants, strengthens the case for RSV vaccination. To inform the design and delivery of public health interventions, long-term surveillance is required to establish regional heterogeneities in respiratory virus circulation and seasonality.
{"title":"Surveillance of respiratory viruses at health facilities from across Kenya, 2014.","authors":"Nickson Murunga, Bryan Nyawanda, Joyce U Nyiro, Grieven P Otieno, Everlyn Kamau, Charles N Agoti, Clement Lewa, Alex Gichuki, Martin Mutunga, Nancy Otieno, Lilian Mayieka, Melvin Ochieng, Gilbert Kikwai, Elizabeth Hunsperger, Clayton Onyango, Gideon Emukule, Godfrey Bigogo, Jennifer R Verani, Sandra S Chaves, D James Nokes, Patrick K Munywoki","doi":"10.12688/wellcomeopenres.17908.4","DOIUrl":"10.12688/wellcomeopenres.17908.4","url":null,"abstract":"<p><strong>Background: </strong>Acute respiratory illnesses (ARI) are a major cause of morbidity and mortality globally. With (re)emergence of novel viruses and increased access to childhood bacterial vaccines, viruses have assumed greater importance in the aetiology of ARI. There are now promising candidate vaccines against some of the most common endemic respiratory viruses. Optimal delivery strategies for these vaccines, and the need for interventions against other respiratory viruses, requires geographically diverse data capturing temporal variations in virus circulation.</p><p><strong>Methods: </strong>We leveraged three health facility-based respiratory illness surveillance platforms operating in 11 sites across Kenya. Nasopharyngeal (NP) and/or oropharyngeal (OP) specimens, patient demographic, and clinical characteristics were collected in 2014 from individuals of various ages presenting with respiratory symptoms at the surveillance facilities. Real time multiplex polymerase chain reaction was used to detect rhinoviruses, respiratory syncytial virus (RSV), influenza virus, human coronaviruses (hCoV), and adenoviruses.</p><p><strong>Results: </strong>From 11 sites, 5451 NP/OP specimens were collected and tested from patients. Of these, 40.2% were positive for at least one of the targeted respiratory viruses. The most frequently detected were rhinoviruses (17.0%) and RSV A/B (10.5%), followed by influenza A (6.2%), adenovirus (6.0%) and hCoV (4.2%). RSV was most prevalent among infants aged <12 months old (18.9%), adenovirus among children aged 12-23 months old (11.0%), influenza A among children aged 24-59 months (9.3%), and rhinovirus across all age groups (range, 12.7-19.0%). RSV had a higher virus positivity in the inpatient setting (12.5%) compared to outpatient setting (4.8%). The overall percent virus positivity varied by surveillance site, health facility type and case definition used in surveillance.</p><p><strong>Conclusions: </strong>We identify rhinoviruses, RSV, and influenza A as the most prevalent respiratory viruses. Higher RSV positivity in inpatients, and in infants, strengthens the case for RSV vaccination. To inform the design and delivery of public health interventions, long-term surveillance is required to establish regional heterogeneities in respiratory virus circulation and seasonality.</p>","PeriodicalId":23677,"journal":{"name":"Wellcome Open Research","volume":"7 ","pages":"234"},"PeriodicalIF":0.0,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12848351/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146120156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Nutritional practices during early life are critical in shaping long-term health outcomes. Poor or inappropriate nutrition may influence adiposity gain and the overall cardiometabolic risk among children born with low birth weight. Our study investigates how early feeding patterns, the timing of adiposity rebound, and DNA methylation of key genes influence cardiometabolic health at two years in low-birth-weight children.
Methods: This study will be conducted as a longitudinal follow-up study among children with low birth weight (children born with a birth weight of less than 2500 grams). A thousand four hundred children will be recruited consecutively for this study. Birth weight, gestational age, and early neonatal and perinatal details will be collected from clinical records. Information on sociodemographic characteristics, dietary practices, and antenatal, obstetric, and postnatal histories will also be collected. The two-year follow-up assessment will include anthropometric measurements (height, weight, head circumference, chest circumference, waist circumference, and skinfold thickness) and blood pressure. Biochemical investigations will include a lipid profile, serum proteins, insulin resistance assessment, and hemoglobin levels. In addition, DNA methylation at six specific CpG sites relevant to adipogenesis and cardiometabolic health will be assessed. Left ventricular mass and ejection fraction will be evaluated using echocardiography. Carotid intima-media thickness will be measured using an appropriate ultrasound probe. The neurodevelopmental status of the children will be assessed using the Developmental Assessment Scales for Indian Infants (DASII) and Vineland Social Maturity Scale (VSMS).
Conclusions: Elucidating the impact of early life nutritional practices is vital for promoting cardiometabolic health. This understanding supports the formulation of tailored feeding interventions that are essential for safeguarding cardiovascular health in children with low birth weight.
{"title":"Nutritional Influences on Adiposity Rebound and Cardiometabolic Outcomes in a Prospective Birth Cohort of Low-Birth-Weight Children: A Study Protocol.","authors":"Neethu Thulaseedharan, Liss Maria Scaria, Srikant Ambatipudi, Deepa Bhaskaran, Sankar Hariharan, Akhila Sureshbabu, Panniyammakal Jeemon, Arun Gopalakrishnan","doi":"10.12688/wellcomeopenres.24589.2","DOIUrl":"10.12688/wellcomeopenres.24589.2","url":null,"abstract":"<p><strong>Background: </strong>Nutritional practices during early life are critical in shaping long-term health outcomes. Poor or inappropriate nutrition may influence adiposity gain and the overall cardiometabolic risk among children born with low birth weight. Our study investigates how early feeding patterns, the timing of adiposity rebound, and DNA methylation of key genes influence cardiometabolic health at two years in low-birth-weight children.</p><p><strong>Methods: </strong>This study will be conducted as a longitudinal follow-up study among children with low birth weight (children born with a birth weight of less than 2500 grams). A thousand four hundred children will be recruited consecutively for this study. Birth weight, gestational age, and early neonatal and perinatal details will be collected from clinical records. Information on sociodemographic characteristics, dietary practices, and antenatal, obstetric, and postnatal histories will also be collected. The two-year follow-up assessment will include anthropometric measurements (height, weight, head circumference, chest circumference, waist circumference, and skinfold thickness) and blood pressure. Biochemical investigations will include a lipid profile, serum proteins, insulin resistance assessment, and hemoglobin levels. In addition, DNA methylation at six specific CpG sites relevant to adipogenesis and cardiometabolic health will be assessed. Left ventricular mass and ejection fraction will be evaluated using echocardiography. Carotid intima-media thickness will be measured using an appropriate ultrasound probe. The neurodevelopmental status of the children will be assessed using the Developmental Assessment Scales for Indian Infants (DASII) and Vineland Social Maturity Scale (VSMS).</p><p><strong>Conclusions: </strong>Elucidating the impact of early life nutritional practices is vital for promoting cardiometabolic health. This understanding supports the formulation of tailored feeding interventions that are essential for safeguarding cardiovascular health in children with low birth weight.</p>","PeriodicalId":23677,"journal":{"name":"Wellcome Open Research","volume":"10 ","pages":"473"},"PeriodicalIF":0.0,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12550497/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145378942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-05eCollection Date: 2025-01-01DOI: 10.12688/wellcomeopenres.24371.1
Anna Mensah, Rebecca Symes, Chengetai Mpamhanga, Nick Andrews, Lynne Ferguson, Rory Gunson, Katja Hoschler, Beatrix Kele, Wei Shen Lim, Jamie Lopez Bernal, Ross McQueenie, Chris Robertson, Tiina Talts, Heather Whitaker, Kimberly Marsh, Conall Watson, Maria Zambon, Thomas Williams
Background: Respiratory syncytial virus (RSV) is a virus with two antigenic types, A and B, that cause significant morbidity and mortality in infants globally. A recently developed maternal vaccination based on the prefusion F protein ("RSVpreF") could have a significant impact on disease burden, if introduced globally. Whether or not the effectiveness of this vaccine is affected by circulating viral genomic variability is currently unknown.
Objectives: To examine whether the vaccine effectiveness of maternal RSVpreF administration in preventing hospitalisation in infants is affected by RSV type or lineage.
Methods: We will conduct whole genome sequencing of RSV positive samples from infants hospitalised with acute lower respiratory tract infection (ALRI) in the 2024-2025 winter season, at multiple hospitals in England and Scotland, to calculate the relative vaccine effectiveness (rVE) of maternal RSVpreF vaccination by virus type (RSV-A and RSV-B). rVE will be calculated using a case control logistic regression with adjustment by infant age and admission date; sex, socioeconomic status and hospital location will be included as potential confounders if they are associated with a >3% change in rVE. We will also perform a test negative design to examine the VE for RSV-A and RSV-B separately, using RSV-negative controls from hospitals where cases were admitted. Finally, we will compare viral lineages in vaccinated versus unvaccinated infants.
Results and conclusions: Our study will identify whether currently circulating RSV genomic variability impacts on rVE. Confirmation of the null hypothesis - that there is no impact of viral genomic variability on rVE - will provide reassurance to policymakers and public health bodies as RSVpreF is rolled out globally. Conversely, an association between RSV type or lineage and decreased vaccine effectiveness will highlight the need for the enhanced comprehensive national and global molecular surveillance of RSV.
{"title":"Study protocol: Effectiveness of the maternal RSVpreF vaccine by virus type.","authors":"Anna Mensah, Rebecca Symes, Chengetai Mpamhanga, Nick Andrews, Lynne Ferguson, Rory Gunson, Katja Hoschler, Beatrix Kele, Wei Shen Lim, Jamie Lopez Bernal, Ross McQueenie, Chris Robertson, Tiina Talts, Heather Whitaker, Kimberly Marsh, Conall Watson, Maria Zambon, Thomas Williams","doi":"10.12688/wellcomeopenres.24371.1","DOIUrl":"10.12688/wellcomeopenres.24371.1","url":null,"abstract":"<p><strong>Background: </strong>Respiratory syncytial virus (RSV) is a virus with two antigenic types, A and B, that cause significant morbidity and mortality in infants globally. A recently developed maternal vaccination based on the prefusion F protein (\"RSVpreF\") could have a significant impact on disease burden, if introduced globally. Whether or not the effectiveness of this vaccine is affected by circulating viral genomic variability is currently unknown.</p><p><strong>Objectives: </strong>To examine whether the vaccine effectiveness of maternal RSVpreF administration in preventing hospitalisation in infants is affected by RSV type or lineage.</p><p><strong>Methods: </strong>We will conduct whole genome sequencing of RSV positive samples from infants hospitalised with acute lower respiratory tract infection (ALRI) in the 2024-2025 winter season, at multiple hospitals in England and Scotland, to calculate the relative vaccine effectiveness (rVE) of maternal RSVpreF vaccination by virus type (RSV-A and RSV-B). rVE will be calculated using a case control logistic regression with adjustment by infant age and admission date; sex, socioeconomic status and hospital location will be included as potential confounders if they are associated with a >3% change in rVE. We will also perform a test negative design to examine the VE for RSV-A and RSV-B separately, using RSV-negative controls from hospitals where cases were admitted. Finally, we will compare viral lineages in vaccinated versus unvaccinated infants.</p><p><strong>Results and conclusions: </strong>Our study will identify whether currently circulating RSV genomic variability impacts on rVE. Confirmation of the null hypothesis - that there is no impact of viral genomic variability on rVE - will provide reassurance to policymakers and public health bodies as RSVpreF is rolled out globally. Conversely, an association between RSV type or lineage and decreased vaccine effectiveness will highlight the need for the enhanced comprehensive national and global molecular surveillance of RSV.</p>","PeriodicalId":23677,"journal":{"name":"Wellcome Open Research","volume":"10 ","pages":"664"},"PeriodicalIF":0.0,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12770888/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145918637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-04eCollection Date: 2024-01-01DOI: 10.12688/wellcomeopenres.22720.2
Souphaphone Vannachone, Anouphet Chanthamavong, Malavanh Vongsouvath, Phetkim Sayasene, Manivanh Vongsouvath, Audrey Dubot-Pérès, Elizabeth A Ashley, Terry John Evans
Background: Neurological symptoms following head trauma are common; however, the cause may not always be obvious. In the absence of open wounds, fractures, or surgical interventions, infectious causes may not be considered, especially viral infections such as Herpes simplex, and investigations may not be targeted to investigate this possibility.
Case: A 39-year-old male presented with a severe headache, reduced consciousness, and confusion. Two days earlier, he had been discharged from the hospital, where he had been treated for traumatic brain injury with subarachnoid hemorrhage following a road traffic accident. Herpes simplex virus type 2 (HSV-2) was detected in the cerebrospinal fluid, confirming the diagnosis of viral meningoencephalitis. He was treated with oral aciclovir for two weeks and achieved full neurological recovery.
Conclusions: This case highlights the risk of viral reactivation following trauma, particularly head injuries. Central nervous system infections, including viral infections, should be considered in cases of delayed deterioration following trauma, likely presenting with worsening headache, drowsiness and reduced cognitive state. The optimal treatment of herpes simplex virus (HSV) encephalitis may be challenging in resource-limited settings.
{"title":"Case Report: Herpes simplex virus type 2 (HSV-2) meningo-encephalitis associated with traumatic brain injury - a case report from Lao PDR.","authors":"Souphaphone Vannachone, Anouphet Chanthamavong, Malavanh Vongsouvath, Phetkim Sayasene, Manivanh Vongsouvath, Audrey Dubot-Pérès, Elizabeth A Ashley, Terry John Evans","doi":"10.12688/wellcomeopenres.22720.2","DOIUrl":"10.12688/wellcomeopenres.22720.2","url":null,"abstract":"<p><strong>Background: </strong>Neurological symptoms following head trauma are common; however, the cause may not always be obvious. In the absence of open wounds, fractures, or surgical interventions, infectious causes may not be considered, especially viral infections such as Herpes simplex, and investigations may not be targeted to investigate this possibility.</p><p><strong>Case: </strong>A 39-year-old male presented with a severe headache, reduced consciousness, and confusion. Two days earlier, he had been discharged from the hospital, where he had been treated for traumatic brain injury with subarachnoid hemorrhage following a road traffic accident. Herpes simplex virus type 2 (HSV-2) was detected in the cerebrospinal fluid, confirming the diagnosis of viral meningoencephalitis. He was treated with oral aciclovir for two weeks and achieved full neurological recovery.</p><p><strong>Conclusions: </strong>This case highlights the risk of viral reactivation following trauma, particularly head injuries. Central nervous system infections, including viral infections, should be considered in cases of delayed deterioration following trauma, likely presenting with worsening headache, drowsiness and reduced cognitive state. The optimal treatment of herpes simplex virus (HSV) encephalitis may be challenging in resource-limited settings.</p>","PeriodicalId":23677,"journal":{"name":"Wellcome Open Research","volume":"9 ","pages":"489"},"PeriodicalIF":0.0,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715399/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145805592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-02eCollection Date: 2025-01-01DOI: 10.12688/wellcomeopenres.23491.2
Dimitrios Bellos, James Allsopp, Elaine M L Ho, Tibor Auer, Gavin Yearwood, Andrew J Morris, Mark Basham
Despite significant investment in High-Performance Computing (HPC) clusters by funding councils, there are still many researchers whose workflows could not benefit from the computation speed that is provided by these clusters. Reducing barriers to entry for these researchers would accelerate their scientific throughput, since they will be able to respond to results in a timely fashion, improving either their protocols or correcting any problems that might have arisen. This improves the quality of science, and therefore the return on investment, in computationally-intensive areas such as Cryogenic Electron Microscopy (cryo-EM). This paper outlines a technique, FlowCron, for users to analyse their data on a HPC facility with reduced training, increasing accessibility. FlowCron transfers the responsibilities of installation and upkeep of data processing pipelines from users to HPC project PIs and/or HPC project managers, simplifies the set up of HPC pipelines, and makes pipelines as reliable as possible once set up. The work described here has software dependencies that are common to the majority of HPC clusters. We achieve this by linking Globus and cron to produce an open-source system that requires little administrative support but provides a very easy way of running an analysis on a HPC system. The user starts the analysis through the Globus website and, when started, the data will be encrypted, uploaded to the HPC, analysed, and returned to the originating machine, along with a record of the analysis. For Globus to transfer any data to and from the HPC, appropriate user authentication is required, thus ensuring that only authorised users can send data in the HPC.
{"title":"FlowCron - Increasing access to HPC by wrapping Globus into a function-as-a-service.","authors":"Dimitrios Bellos, James Allsopp, Elaine M L Ho, Tibor Auer, Gavin Yearwood, Andrew J Morris, Mark Basham","doi":"10.12688/wellcomeopenres.23491.2","DOIUrl":"10.12688/wellcomeopenres.23491.2","url":null,"abstract":"<p><p>Despite significant investment in High-Performance Computing (HPC) clusters by funding councils, there are still many researchers whose workflows could not benefit from the computation speed that is provided by these clusters. Reducing barriers to entry for these researchers would accelerate their scientific throughput, since they will be able to respond to results in a timely fashion, improving either their protocols or correcting any problems that might have arisen. This improves the quality of science, and therefore the return on investment, in computationally-intensive areas such as Cryogenic Electron Microscopy (cryo-EM). This paper outlines a technique, FlowCron, for users to analyse their data on a HPC facility with reduced training, increasing accessibility. FlowCron transfers the responsibilities of installation and upkeep of data processing pipelines from users to HPC project PIs and/or HPC project managers, simplifies the set up of HPC pipelines, and makes pipelines as reliable as possible once set up. The work described here has software dependencies that are common to the majority of HPC clusters. We achieve this by linking Globus and cron to produce an open-source system that requires little administrative support but provides a very easy way of running an analysis on a HPC system. The user starts the analysis through the Globus website and, when started, the data will be encrypted, uploaded to the HPC, analysed, and returned to the originating machine, along with a record of the analysis. For Globus to transfer any data to and from the HPC, appropriate user authentication is required, thus ensuring that only authorised users can send data in the HPC.</p>","PeriodicalId":23677,"journal":{"name":"Wellcome Open Research","volume":"10 ","pages":"4"},"PeriodicalIF":0.0,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11885907/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143587331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-25eCollection Date: 2024-01-01DOI: 10.12688/wellcomeopenres.20738.2
Arwen F Altenburg, Jack L Morley, Sophia M Decatris, Jens Bauer, Juliane S Walz, Louise H Boyle
Background: Major histocompatibility class I (MHC-I, human leukocyte antigen [HLA] class I in humans) molecules present small fragments of the proteome on the cell surface for immunosurveillance, which is pivotal to control infected and malignant cells. Immunogenic peptides are generated and selected in the MHC-I antigen processing and presentation pathway. In this pathway, two homologous molecules, tapasin and TAPBPR, optimise the MHC-I peptide repertoire that is ultimately presented at the plasma membrane. Peptide exchange on HLA class I by human TAPBPR involves the flexible loop region K22-D35, with the leucine at position 30 (L30) involved in mediating peptide dissociation. However, our understanding of the exact molecular mechanisms governing TAPBPR-mediated peptide exchange on HLA class I allotypes remains incomplete.
Methods: Here, in-depth re-analyses of published immunopeptidomics datasets was used to further examine TAPBPR peptide editing activity and mechanism of action on HLA class I. The role of the TAPBPR editing loop in opening the HLA class I peptide binding groove was assessed using molecular dynamics simulations and a peptide exchange assay.
Results: We show that TAPBPR shapes the peptide repertoire on HLA-A, -B and -C allotypes. The TAPBPR editing loop was not essential to allow HLA class I to adopt an open state but did allow for the HLA-A*68:02 peptide binding groove to stay open for a sustained period. L30 in the TAPBPR editing loop was typically sufficient to mediate peptide repertoire restriction on the three HLA class I allotypes expressed by HeLa cells. TAPBPR was also able to load peptides onto HLA class I in a loop-dependent manner.
Conclusions: These results suggest that the TAPBPR editing loop is involved both in peptide filtering and loading.
{"title":"Reanalysis of Immunopeptidomics Datasets Provides Mechanistic Insight into TAPBPR-Mediated Peptide Editing on HLA-A, -B and -C Molecules.","authors":"Arwen F Altenburg, Jack L Morley, Sophia M Decatris, Jens Bauer, Juliane S Walz, Louise H Boyle","doi":"10.12688/wellcomeopenres.20738.2","DOIUrl":"https://doi.org/10.12688/wellcomeopenres.20738.2","url":null,"abstract":"<p><strong>Background: </strong>Major histocompatibility class I (MHC-I, human leukocyte antigen [HLA] class I in humans) molecules present small fragments of the proteome on the cell surface for immunosurveillance, which is pivotal to control infected and malignant cells. Immunogenic peptides are generated and selected in the MHC-I antigen processing and presentation pathway. In this pathway, two homologous molecules, tapasin and TAPBPR, optimise the MHC-I peptide repertoire that is ultimately presented at the plasma membrane. Peptide exchange on HLA class I by human TAPBPR involves the flexible loop region K22-D35, with the leucine at position 30 (L30) involved in mediating peptide dissociation. However, our understanding of the exact molecular mechanisms governing TAPBPR-mediated peptide exchange on HLA class I allotypes remains incomplete.</p><p><strong>Methods: </strong>Here, in-depth re-analyses of published immunopeptidomics datasets was used to further examine TAPBPR peptide editing activity and mechanism of action on HLA class I. The role of the TAPBPR editing loop in opening the HLA class I peptide binding groove was assessed using molecular dynamics simulations and a peptide exchange assay.</p><p><strong>Results: </strong>We show that TAPBPR shapes the peptide repertoire on HLA-A, -B and -C allotypes. The TAPBPR editing loop was not essential to allow HLA class I to adopt an open state but did allow for the HLA-A*68:02 peptide binding groove to stay open for a sustained period. L30 in the TAPBPR editing loop was typically sufficient to mediate peptide repertoire restriction on the three HLA class I allotypes expressed by HeLa cells. TAPBPR was also able to load peptides onto HLA class I in a loop-dependent manner.</p><p><strong>Conclusions: </strong>These results suggest that the TAPBPR editing loop is involved both in peptide filtering and loading.</p>","PeriodicalId":23677,"journal":{"name":"Wellcome Open Research","volume":"9 ","pages":"113"},"PeriodicalIF":0.0,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11126903/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145640487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-24eCollection Date: 2025-01-01DOI: 10.12688/wellcomeopenres.25215.1
Susan J Skipp, Andrew Morrise
We present a genome assembly from an individual Erpobdella octoculata (leeches; Annelida; Clitellata; Hirudinida; Erpobdellidae). The genome sequence has a total length of 386.12 megabases. Most of the assembly (98.81%) is scaffolded into 10 chromosomal pseudomolecules. The mitochondrial genome has also been assembled, with a length of 19.12 kilobases. Gene annotation of this assembly on Ensembl identified 19 465 protein-coding genes. This assembly was generated as part of the Darwin Tree of Life project, which produces reference genomes for eukaryotic species found in Britain and Ireland.
{"title":"The genome sequence of the freshwater leech, <i>Erpobdella octoculata</i> (Linnaeus, 1758) (Hirudinida: Erpobdellidae).","authors":"Susan J Skipp, Andrew Morrise","doi":"10.12688/wellcomeopenres.25215.1","DOIUrl":"10.12688/wellcomeopenres.25215.1","url":null,"abstract":"<p><p>We present a genome assembly from an individual <i>Erpobdella octoculata</i> (leeches; Annelida; Clitellata; Hirudinida; Erpobdellidae). The genome sequence has a total length of 386.12 megabases. Most of the assembly (98.81%) is scaffolded into 10 chromosomal pseudomolecules. The mitochondrial genome has also been assembled, with a length of 19.12 kilobases. Gene annotation of this assembly on Ensembl identified 19 465 protein-coding genes. This assembly was generated as part of the Darwin Tree of Life project, which produces reference genomes for eukaryotic species found in Britain and Ireland.</p>","PeriodicalId":23677,"journal":{"name":"Wellcome Open Research","volume":"10 ","pages":"660"},"PeriodicalIF":0.0,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12881851/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146143498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-24eCollection Date: 2025-01-01DOI: 10.12688/wellcomeopenres.25199.1
Vladimir Blagoderov, Gavin R Broad, Daniel W Hall
We present a genome assembly from an individual female Nothochrysa capitata (a black lacewing; Arthropoda; Insecta; Neuroptera; Chrysopidae). The assembly contains two haplotypes with total lengths of 688.43 megabases and 587.48 megabases. Most of haplotype 1 (78.72%) is scaffolded into 8 chromosomal pseudomolecules, including the W and Z sex chromosomes. Haplotype 2 was assembled to scaffold level. The mitochondrial genome has also been assembled, with a length of 16.43 kilobases. This assembly was generated as part of the Darwin Tree of Life project, which produces reference genomes for eukaryotic species found in Britain and Ireland.
{"title":"The genome sequence of a black lacewing, <i>Nothochrysa capitata</i> (Fabricius, 1793) (Neuroptera: Chrysopidae).","authors":"Vladimir Blagoderov, Gavin R Broad, Daniel W Hall","doi":"10.12688/wellcomeopenres.25199.1","DOIUrl":"10.12688/wellcomeopenres.25199.1","url":null,"abstract":"<p><p>We present a genome assembly from an individual female <i>Nothochrysa capitata</i> (a black lacewing; Arthropoda; Insecta; Neuroptera; Chrysopidae). The assembly contains two haplotypes with total lengths of 688.43 megabases and 587.48 megabases. Most of haplotype 1 (78.72%) is scaffolded into 8 chromosomal pseudomolecules, including the W and Z sex chromosomes. Haplotype 2 was assembled to scaffold level. The mitochondrial genome has also been assembled, with a length of 16.43 kilobases. This assembly was generated as part of the Darwin Tree of Life project, which produces reference genomes for eukaryotic species found in Britain and Ireland.</p>","PeriodicalId":23677,"journal":{"name":"Wellcome Open Research","volume":"10 ","pages":"657"},"PeriodicalIF":0.0,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12805232/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145999044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-24eCollection Date: 2025-01-01DOI: 10.12688/wellcomeopenres.23711.2
Bethany M Bartlett, Juan Carlos Acosta, Wendy A Bickmore
Background: The nuclear basket is a 'fishtrap'-like structure on the nucleoplasmic face of the nuclear pore complex which has been implicated in diverse functions including RNA export, heterochromatin organisation, and mitosis. Recently, a novel component of the nuclear basket, ZC3HC1, has been described. The localisation of ZC3HC1 to nuclear pores has been reported to occur reciprocally with TPR, a major structural component of the nuclear basket.
Methods: Using siRNA-mediated knock down, immunofluorescence and RNA sequencing we compare the consequences of depleting two proteins of the nuclear pore basket - TPR and ZC3HC1.
Results: We show that in human fibroblasts, although ZC3HC1 localisation to nuclear pores is TPR-dependent, TPR remains localised to pores when ZC3HC1 is depleted. Consistent with this, during oncogene-induced senescence, knockdown of ZC3HC1 does not compromise the formation of senescence-associated heterochromatin foci or activation of the senescence-associated secretory phenotype, which are both known to depend on the presence of TPR at the nuclear basket. We demonstrate that knockdown of TPR and ZC3HC1, although partially overlapping, also have many distinct transcriptional features.
Conclusions: Our results suggest that there is limited overlap in function between these two nuclear basket proteins in human diploid fibroblasts.
{"title":"ZC3HC1 has many functions distinct from TPR and is dispensable for TPR localisation to the nuclear basket.","authors":"Bethany M Bartlett, Juan Carlos Acosta, Wendy A Bickmore","doi":"10.12688/wellcomeopenres.23711.2","DOIUrl":"10.12688/wellcomeopenres.23711.2","url":null,"abstract":"<p><strong>Background: </strong>The nuclear basket is a 'fishtrap'-like structure on the nucleoplasmic face of the nuclear pore complex which has been implicated in diverse functions including RNA export, heterochromatin organisation, and mitosis. Recently, a novel component of the nuclear basket, ZC3HC1, has been described. The localisation of ZC3HC1 to nuclear pores has been reported to occur reciprocally with TPR, a major structural component of the nuclear basket.</p><p><strong>Methods: </strong>Using siRNA-mediated knock down, immunofluorescence and RNA sequencing we compare the consequences of depleting two proteins of the nuclear pore basket - TPR and ZC3HC1.</p><p><strong>Results: </strong>We show that in human fibroblasts, although ZC3HC1 localisation to nuclear pores is TPR-dependent, TPR remains localised to pores when ZC3HC1 is depleted. Consistent with this, during oncogene-induced senescence, knockdown of ZC3HC1 does not compromise the formation of senescence-associated heterochromatin foci or activation of the senescence-associated secretory phenotype, which are both known to depend on the presence of TPR at the nuclear basket. We demonstrate that knockdown of TPR and ZC3HC1, although partially overlapping, also have many distinct transcriptional features.</p><p><strong>Conclusions: </strong>Our results suggest that there is limited overlap in function between these two nuclear basket proteins in human diploid fibroblasts.</p>","PeriodicalId":23677,"journal":{"name":"Wellcome Open Research","volume":"10 ","pages":"188"},"PeriodicalIF":0.0,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12120416/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144181608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}